Amended and Restated EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 14th, 2018 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Restated Agreement”) is executed on the 11th day of March, 2018 (the “Effective Date”) by and between Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jay P. Madan (the “Executive”). The Executive and the Company may be referred to herein as a “Party” or collectively as the “Parties.”
Amended and Restated EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 14th, 2018 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Restated Agreement”) is executed on the 11th day of March, 2018 (the “Effective Date”) by and between Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Christopher P. Prior, Ph.D. (the “Executive”). The Executive and the Company may be referred to herein as a “Party” or collectively as the “Parties.”
Amended and Restated EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 14th, 2018 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Restated Agreement”) is executed on the 11th day of March, 2018 (the “Effective Date”) by and between Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Sandeep Laumas, MD (the “Executive”). The Executive and the Company may be referred to herein as a “Party” or collectively as the “Parties.”